We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MDD Drug Dropped by AstraZeneca, Targacept After Phase III Failures
MDD Drug Dropped by AstraZeneca, Targacept After Phase III Failures
March 23, 2012
AstraZeneca (AZ) and Targacept are pulling the plug on their investigational drug for major depressive disorder (MDD), TC-5214, after two more Phase III trials came up short.